Same industry

RPRX against four drug peers, a year at 100

80100120140160180Feb ’26MayAugNov ’26LLY+33.6%JNJ+36.7%ABBV+23.9%MRK+46.7%RPRX+76.5%

RPRX +76.5%. Merck +46.7%, Johnson & Johnson +36.7%, Eli Lilly +33.6%, AbbVie +23.9%. Weekly closes, Nov 21, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in RPRX’s SEC industry (Pharmaceutical Preparations) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

RPRX: stories, the record and filings →